Placebo
Substance or treatment of no therapeutic value
Ratings
0
Nobody has rated this yet. Be the first!
Influences rating
Influences rating
Subject of
38
A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania
Commentary on a Randomized Placebo-Controlled, Double-Blind, Half-Head Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia
A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis
Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder
Gefitinib versus placebo in completely resected non-small-cell lung cancer: results of the NCIC CTG BR19 study
Acupuncture versus placebo for the treatment of chronic mechanical neck pain: a randomized, controlled trial
A Phase 2, Randomized, Dose-Finding Study of the Novel Once-Weekly Human GLP-1 Analog, Semaglutide, Compared With Placebo and Open-Label Liraglutide in Patients With Type 2 Diabetes
Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial.
Inhaled nitric oxide and cognition in pediatric severe malaria: A randomized double-blind placebo controlled trial
Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial
Lists
0
